Skip to main content
Human Molecular Genetics logoLink to Human Molecular Genetics
. 2021 Nov 11;31(9):1417–1429. doi: 10.1093/hmg/ddab326

Loss of α-actinin-3 confers protection from eccentric contraction damage in fast-twitch EDL muscles from aged mdx dystrophic mice by reducing pathological fibre branching

Leonit Kiriaev 1,, Peter J Houweling 2,3, Kathryn N North 4,5, Stewart I Head 6,7
PMCID: PMC9071495  PMID: 34761268

Abstract

The common null polymorphism (R577X) in the ACTN3 gene is present in over 1.5 billion people worldwide and results in the absence of the protein α-actinin-3 from the Z-discs of fast-twitch skeletal muscle fibres. We have previously reported that this polymorphism is a modifier of dystrophin-deficient Duchenne Muscular Dystrophy. To investigate the mechanism underlying this, we use a double knockout (dk)Actn3KO/mdx (dKO) mouse model, which lacks both dystrophin and sarcomere α-actinin-3. We used dKO mice and mdx dystrophic mice at 12 months (aged) to investigate the correlation between morphological changes to the fast-twitch dKO EDL and the reduction in force deficit produced by an in vitro eccentric contraction protocol. In the aged dKO mouse, we found a marked reduction in fibre branching complexity that correlated with protection from eccentric contraction induced force deficit. Complex branches in the aged dKO EDL fibres (28%) were substantially reduced compared to aged mdx EDL fibres (68%), and this correlates with a graded force loss over three eccentric contractions for dKO muscles (~36% after first contraction, ~66% overall) compared to an abrupt drop in mdx upon the first eccentric contraction (~75% after first contraction, ~89% after three contractions). In dKO, protection from eccentric contraction damage was linked with a doubling of SERCA1 pump density the EDL. We propose that the increased oxidative metabolism of fast-twitch glycolytic fibres characteristic of the null polymorphism (R577X) and increase in SR Ca2+ pump proteins reduces muscle fibre branching and decreases susceptibility to eccentric injury in the dystrophinopathies.

Introduction

Recent progress in gene-based therapies for Duchenne Muscular Dystrophy (DMD) shows the potential to improve the outcomes for boys living with muscular dystrophy (1–4). However, clinical trials have yet to provide pathways for these genetic treatments to be translated into clinical practice (5–8). Some of the problems that occur are due to the genetic variability present among patients in the trials; thus, there has been increased interest in identification of genetic modifiers to DMD. Studies have shown that the TGF-B pathway is a key activator of fibrosis in mdx mice and it is upregulated in DMD, where a late stage pathology of skeletal muscle is the presence of large amounts of non-contractile fibrotic material. The activity of the TGF-B pathway can be influenced by genetic modifiers such as osteopontin and LTBP4 (9) potentially to reduce the amount of skeletal muscle fibrosis present in the dystrophinopathies. In a recent study by our group (10) investigating the common null polymorphism (R577X, rs1815739) in the ACTN3 gene and its interaction with the mutated dystrophin gene in (DMD), we found young ambulant DMD boys had reduced muscle strength and slower 10 meter walking speeds when the gene was absent. Our study also found young double knockout (dk)Actn3KO/mdx (dKO) mice also had reduced muscle strength, but no differences in the degree of force deficit produced in fast-twitch muscles by eccentric contractions when compared to young mdx. In contrast, fast-twitch muscles from aged dKO mice were relatively protected from eccentric contraction (EC) force deficits compared to age matched mdx counterparts. Intriguingly, this suggests that the R577X polymorphism can have an age related ameliorating effect on muscle pathology in the dystrophinopathies. The polymorphism in the ACTN3 gene occurs in an estimated ~16% of people worldwide (11,12) resulting in an absence of the protein α-actinin-3 from the Z-discs of fast-twitch fibres. α-Actinin-3 is localized to the Z-discs of fast-twitch muscle fibres cross-linking the actin filaments of adjoining sarcomeres and interacts with a host of metabolic and signalling proteins (13). The main role of the Z-disc is to transmit movement and force generated by the contractile proteins, longitudinally to the tendons (14). The absence of α-actinin-3 from fast-twitch fibres does not result in any muscle pathology; on the contrary, it appears it may in fact be beneficial for endurance activities in humans (15), although it should be noted that several human studies (underpowered with interference from varied genetic backgrounds) do not provide support for the absence of α-actinin-3 improving human endurance (for a review see Houweling et al. (16)). In order to circumvent this genetic variability in humans we developed an animal model, the Actn3KO mouse, which is genetically identical to its littermate controls apart from the absence of α-actinin-3. Using this model, we have shown that α-actinin-3 significantly improves resistance to fatigue in fast-twitch muscles (17–19). We have also shown upregulated expression of the SERCA1 Ca2+ pumps in fast-twitch muscles of Actn3KO mice that result in increased Ca2+ cycling at the intracellular Ca2+ store (the sarcoplasmic reticulum). The increased metabolic load required to pump the additional Ca2+ leak in α-actinin-3-deficient fast-twitch fibres may be a mechanism that explains the positive selection pressure during recent human evolution on the R577X polymorphism, as it would result in enhanced acclimatization to the low environmental temperatures experienced by modern humans migrating out of Africa into the cold northern hemisphere over the last 60 000 years (20). Further support of the positive evolutionary selection pressure in humans comes from our recent study showing that absence of α-actinin-3 is correlated to improved resistance to cold water immersion (21). In the Actn3KO mouse, there is no change in the fibre types found in fast-twitch muscles with respect to myosin heavy chain expression (18,22), however, fast fibres have reduced muscle fibre diameter (22) & mass (17,18), increased oxidative metabolism (22–24) and a slowed relaxation after contraction in young male animals (18). These skeletal muscle results can explain our recent findings (10) that in young ambulant boys with DMD and the ACTN3 null polymorphism (R577X) is correlated with reduced muscle strength and longer 10 m walk test time. Because of the implications for the presence of ACTN3 in ~16% of boys with DMD, in this current paper we verify and extended the animal experiments from Hogarth et al. (10) in a new cohort of mice aged to 12 months. The 12 month age group was selected because we have previously demonstrated that by this age mdx fast-twitch EDL muscles are irreversibly damaged by a single EC, and this irreversible eccentric force deficit is correlated with the number and complexity of branched dystrophic fibres present (25,26). We found convincing correlative evidence that the age-related protective effect conferred by the absence of α-actinin-3 is due to the reduction in the number and complexity of pathologically branched dystrophic fibres. Additionally, we propose that the mechanism by which the polymorphism R577X induces this protective effect in the dystrophinopathies is due to a switch in the fast-twitch fibres to a more oxidative metabolism and an increase in the SERCA1 pumps, both of which are known to be protective in the dystrophinopathies (20,27–31).

Results

Muscle mass, optimal length and twitch kinetics

The optimal muscle length Lo for both groups was identical, while dKO mass was slightly higher than aged mdx muscles (MD 2.466, 95% CI [−0.128, 5.059], P = 0.06), this was not statistically different (Table 1). Before the EC protocol was administered the twitch kinetics of the aged mdx and dKO were the same, post-EC the aged mdx showed a significant decrease in the time to peak and a depressed twitch/tetanus ratio c.f. the post-EC dKO (see statistics in Table 1). Interestingly, no differences in twitch half relaxation time was seen before and after the EC protocol between groups; however, overall there was an increase in both aged mdx (MD 4.6, 95% CI [1.274, 7.926], P = 0.019, paired t-test) and dKO (MD 3.13, 95% CI [1.232, 5.018], P = 0.006, paired t-test) half relaxation time post-EC.

Table 1.

General physical properties and twitch kinetics of aged mdx and dKO EDL muscles. General physical properties: Muscle optimal length producing maximal force and muscle mass. Twitch kinetics: values before and after EC are presented for time to peak, half relaxation time and twitch to tetanus ratio. All data shown are mean ± SD (n = 5 Aged mdx; n = 8 dKO). P-values shown are assessed by unpaired t-test with a significance established at 0.05, NS labelled for no statistical significance

mdx dKO P-value
General physical properties
Optimum length (mm) 14 ± 0 13.88 ± 0.23 NS
Mass (mg) 20.52 ± 2.07 22.99 ± 2.07 NS
Twitch kinetics
Time to peak, ms (before) 23.8 ± 0.91 23.56 ± 1.05 NS
Time to peak, ms (after) 22.4 ± 0.96 23.75 ± 1.04 0.039
Half relaxation time, ms (before) 16 ± 0.79 15.81 ± 1.44 NS
Half relaxation time, ms (after) 20.6 ± 2.28 18.94 ± 2.64 NS
Twitch to tetanus ratio, % (before) 23.35 ± 4.1 23.88 ± 1.5 NS
Twitch to tetanus ratio, % (after) 21.24 ± 2.5 29.73 ± 4.6 0.0032

Force-frequency parameters, half frequency and hill coefficient were unchanged by eccentric contraction protocol in aged mdx compared to dKO

Figure 1A-C shows aggregate force frequency curves generated from EDL muscle recordings at increasing frequencies from 2–150 Hz. The data from muscles were quantified by non-linear curve fitting using the sigmoidal equation given in the methods. For clarity, data for individual EDL muscles, were expressed as a percentage of maximum force and aggregated into single curves for each group. Fitted population parameters are derived from the curve fitting. Half frequency (Fig. 1D) is the stimulation frequency at which the muscle develops force, which is halfway between its minimum and maximum forces, the hill coefficient (Fig. 1E) is a measure of the slope of the curve. Following EC, significant changes occurred in the aged mdx EDL (but not dKO) with a ~ 10% increase in the half frequency, resulting in a higher post-EC half frequency between groups (MD 8.137, 95% CI [2.947, 13.33], P = 0.0054) (Fig. 1D), and a ~ 48% decrease in the slope (hill coefficient) resulting in a lower post-EC hill coefficient between groups (MD −3.015, 95% CI [−4.439, −1.591], P = 0.0007) (Fig. 1E). From the curve fitting we calculated a post-EC force deficit of ~67% for dKO c.f. ~87% in aged mdx (MD −19.94, 95% CI [−3.685, −36.2], P = 0.021) (Fig. 1B and C).

Figure 1.

Figure 1

Force frequency curves and fitted parameters. (A) Force frequency data from individual EDL muscles were aggregated to produce a single curve for aged mdx and dKO mice to visualize differences between genotypes prior to EC. SD omitted for clarity in A but provided later in B & C (top only). (B and C) Force frequency curves obtained before (solid line) and after (dashed line) the EC protocol for aged mdx and dKO, respectively. (D) Scatterplots of half frequency before and after EC for aged mdx and dKO. (E) Scatterplots of Hill coefficient before and after EC for aged mdx and dKO. All data shown are mean ± SD (n = 5 Aged mdx; n = 8 dKO). P-values shown are assessed by unpaired t-test with a significance established at 0.05, ***0.0001 < P < 0.001 and **0.001 < P < 0.01.

dKO EDL muscles are protected from eccentric contraction induced force deficits despite undergoing a greater ‘work done’ during eccentric contractions

The isometric force deficits after each EC are expressed as a portion of starting force in Figure 2A. The EC force deficit occurred incrementally in the EDL muscles from the dKO with a ~ 36% force deficit on the first EC, in contrast aged mdx EDL muscles showed an abrupt ~75% force deficit on the first EC (MD −36.83, 95% CI [−51.82, −21.85], P = 0.0002) (Fig. 2B left). After the three eccentric contractions EDL muscles from dKO mice lost ~66% of starting force c.f. ~89% EC force deficit in aged mdx (MD −22.06, 95% CI [−34.25, −9.88], P = 0.0021) (Fig. 2B right). We calculated the work done as the area under the force curve during the active lengthening phase of the first EC. Figure 2C illustrates that the work done during the first EC was significantly greater for EDL muscles in dKO animals compared with age matched mdx controls (MD 122.54, 95% CI [48.77, 196.3], P = 0.0038).

Figure 2.

Figure 2

Force loss from EC and work done at 10% strain. (A) XY plot of force loss across the 3 eccentric contractions expressed as a percentage of starting force for aged mdx and dKO EDL. Note: SD presented as top half only. (B) For clarity scatterplots of force loss as a consequence of the first 10% EC (left) and after all 3 eccentric contractions (right) have been provided. (C) Scatterplot showing work done calculated during the first 10% EC for aged mdx and dKO EDL. All data shown are mean ± SD (n = 5 Aged mdx; n = 8 dKO). P-values shown are assessed by unpaired t-test with a significance established at 0.05, ***0.0001 < P < 0.001 and **0.001 < P < 0.01.

There are less complex branched fibres in EDL muscles from dKO mice, which correlates with the protection from eccentric contraction force deficits.

The number and complexity of fibre branching found in EDL muscles of dKO and age matched mdx control groups are shown in Fig. 3 (note these counts represent all fibres counted and there are no error bars). In the aged mdx EDL around 97% of fibres contain branches; ~6% of fibres contain a single branch, ~23% contain 2 or 3 branches and ~68% of all fibres develop complex branches (4 or more branches per fibre). In comparison both the number of branched fibres and the complexity of branching is reduced in dKO EDL. Approximately, 89% of dKO muscle fibres contain branches; ~22% of fibres contain a single branch, ~39% contain 2 or 3 branches and ~28% of all fibres develop complex branches (4 or more branches per fibre).

Figure 3.

Figure 3

The degree of fibre branching in EDL muscles as a percentage of all fibres by categorizing them based on number of branch points. Note this is a bar graph of all fibres counted and as such is an absolute measure, all photomicrographs in Figures 46 were taken from these fibre counts. A total of 667 fibres from 9 EDL muscles were counted; 207 fibres from 4 aged mdx and 460 from 5 dKO animals. Only intact fibres with no evidence of digestion damage were selected for counting.

Light microscope morphology of enzymatically isolated single fibres

Representative images of intact muscle fibres taken at magnification (X100) on a light microscope demonstrate the complexity of fibre branching in the aged mdx EDL (Fig. 4). Panels A and B show some examples of simple branched fibres (1 or 2), panels C-E show more complicated fibre branches (3–4) and panels F-I are examples of long complex branched fibres (4+) with multiple offshoots along the length of the dystrophic fibre.

Figure 4.

Figure 4

Examples of light microscope images (X100) of enzymatically digested EDL muscle fibres taken from aged mdx mice (n = 2 muscles). Note: the fibres in Figures 4 and 5 have been stitched together at the same magnification from photomicrographs taken from overlapping fields of view to capture a large portion of the fibre, scale bar provided at 200 μm in the bottom right corner applies to all panels. Background debris from the digest process have been cleared to focus on the muscle fibre. To see examples where debris have not been removed see Kiriaev et al. (25). Simple branched fibres (1 or 2 branches) can be seen in panels A-B, more complicated fibre branches (3–4 branches) are seen in panels C-E and panels F-I show examples of long complex branched fibres (4+ branches) with multiple offshoots along the length of the fibre.

Images of single EDL fibres from dKO mice taken at magnification (X100) are shown in Figure 5. Figure 5A and D are examples of straight fibres with no branches and panels H & L are examples of more complex fibres found in the dKO muscle. Most dissociated fibres we observed resemble the morphology seen in all other panels in Figure 5, containing 1–3 branches per fibre. When comparing these light microscope images of dissociated fibres Figure 4 c.f. Figure 5, it is evident that the complexity of fibre branching is reduced in dKO mice compared to aged mdx counterparts.

Figure 5.

Figure 5

Examples of light microscope images (X100) of enzymatically digested EDL muscle fibres taken from dKO mice (n = 3 muscles). Scale bar provided at 200 μm in the bottom right corner applies to all panels. Straight fibres with no branching are seen in panels A&D as well as examples of complex branched fibres in panels H&L were also seen in the dKO EDL muscles. The majority of dissociated fibres resemble the morphology in all other panels containing between 1 and 3 branches per fibre.

Figure 6 shows some examples of magnification (X100) light microscope images from dKO EDL muscles where branch points can be seen at higher resolution and contrast. The branch pattern in these dKO fibres range from simple splits or offshoots towards the end of the fibre shown in panels A, G, I & J, to splits that re-join mid fibre in panels B, C, F, H, K and L as well as tapered fibres in panels D & E. Cartoon inserts have been added to each image to help identify broken fibres (Red) and super-contracted areas (Yellow).

Figure 6.

Figure 6

Examples of light microscope images (X100) focusing on the fibre branch point in dKO muscle fibres over one field of view. Cartoon inserts have been added to help visualize the various examples of branching in each image also highlighting broken (Red) and necrotic areas (Yellow). Branchpoint patterns such as simple splits or offshoots towards the end of the fibre shown in panels A, G, I & J to splits that re-join in the middle of fibres shown in panels B, C, F, H, K and L as well as tapered fibres in panels D & E. Scale bar provided at 200 μm in panel L applies to all of Figure 6.

SERCA1 expression

We have previously reported that one consequence of Actn3KO in fast-twitch muscle is an increase in the expression of the fast SR Ca2+ pump SERCA 1. Using the Western Blot technique we analyzed the level of SERCA1 expression in aged dKO mice and age matched mdx (Fig. 7). We observed a 2-fold increase in the amount of SERCA1 protein in EDL muscles collected from dKO mice compared to age matched mdx (MD 1.033, 95% CI [0.736, 1.33], P = 0.0006).

Figure 7.

Figure 7

Expression of SERCA1 in age matched WT, mdx and dKO EDL muscles. A: SERCA1 protein densitometry values normalized to α-skeletal actin and the average of all WT samples. B: Representative western blots that correspond to A. All data shown are mean ± SD (n = 3 WT; n = 3 Aged mdx; n = 3 dKO). P-values shown are assessed by unpaired t-test with a significance established at 0.05, ***0.0001 < P < 0.001.

Discussion

Muscle mass, optimal length and twitch kinetics

At base line these were the same in EDL muscles from 12 month old mdx and dKO mice. This supports our earlier reports that the Actn3KO polymorphism does not alter fibre type distribution or number of fibres in fast-twitch muscle at 12 months of age (19). Muscle twitch kinetics are an important parameter to measure as Peczkowski et al. (32) and colleagues reported twitch kinetics yielded greater statistical significance compared to previously published maximal tetanic force measurements, and proposed the use of kinetics measurements to allow for use of smaller animal groups in mdx mouse studies. Thus, given the number of animals used in the present study we can be confident that the Actn3 polymorphism in our dKO mice has not altered the contractile properties of the fast-twitch EDL muscle when compared to age matched mdx EDL muscles. However, in relation to kinetic parameters, as detailed in Figures 1 and 2, after the EC protocol there are significant differences between the aged mdx and dKO mice. Twitch time to peak (MD 1.35, 95% CI [0.084, 2.616], P = 0.039) and twitch/tetanus ratios (MD 8.45, 95% CI [3.51, 13.46], P = 0.0032) were significantly higher in dKO mice (Table 1). Given it has been reported that a low twitch/tetanus ratio is characteristic of slow-twitch muscle fibres (33) we can draw the conclusion that the Actn3 polymorphism has been protective against EC induced force deficits in fast-twitch fibres from the dKO while in the age matched mdx the fast-fibres have been damaged by the EC protocol, leaving the slower fibres operational, explaining the slower twitch/tetanus ratio and time to peak (Table 1).

Force-frequency parameters

The half frequency and hill coefficient are a measure of the sensitivity of the contractile proteins to Ca2+. The lower the half frequency and the higher the hill coefficient, the greater the degree of sensitivity, so in this case (Fig. 1D and E), the aged mdx EDL has become less sensitive to activation by Ca2+ as a result of the eccentric contractions consistent with our earlier preliminary findings with the dKO mouse (10). The mouse EDL muscle contains a mixture of fast-twitch fibres ~79% type 2B, ~16% type 2X and ~ 4% type 2A (34), and it has been shown that fast-twitch fibres, especially the largest diameter fastest fibre type 2B (19) are highly susceptible to EC-induced force deficits (25,35–40), and normally contain α-actinin-3 in the Z-discs (39), which will be the primary transductor of the eccentric force. Given this, it is likely that the absence of α-actinin-3 in the dKO mice has conferred the fast-twitch fibres with some degree of protection from eccentric damage (see discussion below) and hence there is greater damage to the fast-twitch fibres in the aged mdx EDL, which presents itself as a drop in sensitivity as a result of the remaining force is being generated by the pool of ‘slower’ fast-twitch fibres that remain functional after the eccentric damage. The force frequency parameter values presented here for 12 month old mdx EDL (Fig. 1) are consistent with the values we reported earlier in aged mdx EDL muscles from mice in this age range (25,38,41).

dKO EDL muscles from 12 month old animals are protected from eccentric contraction induced force deficits despite undergoing a greater ‘work done’ during eccentric contractions

In the dystrophinopathies absence of dystrophin triggers skeletal muscle necrosis followed by regeneration, this process continues throughout the life span of mdx mice and DMD boys. The regenerated skeletal muscle fibres are characterized by the presence of centralized nuclei and increasing numbers of abnormal branched fibres, which increase in both number and complexity as the mouse or boy ages. In the later parts of the mdx mouse life (12–24 months), some fibres can have up to 10 branches (25) in a single syncytium with all branched fibres have a single neuromuscular junction (42–44). In fast-twitch muscles, we and others have found a correlation between the extent and complexity of fibre branching and susceptibility to damage from eccentric contractions (18,25,36,38,45–48). In boys with DMD, extensive fibre branching has been associated with an increase in pathological symptoms, such as a reduction in mobility (49,50). We have previously provided evidence that in the absence of α-actinin-3 there is a reduced susceptibility to stretch-induced damage in fast-twitch EDL dystrophic muscles from aged 12 month mdx mice, however, in young 8 week old mice the absence of α-actinin-3 confers no protection from EC force deficits (10). It is important to note that in these 8 week old muscles 100% of the EDL fibres have undergone at least one round of degeneration and regeneration (51), these mice are also from the same α-actinin-3-deficient backgrounds with muscles lacking dystrophin from the inner surface of the sarcolemma.

Here, we extend our earlier finding that absence of α-actinin-3 protects the 12 month fast-twitch mdx EDL muscles from eccentric force deficits even when the work done by our EC protocol is markedly larger in the dKO compared to the more severely damaged aged mdx muscles (Fig. 2C). The reason more work was done in dKO for a given eccentric stretch is because the protective effect of an absence of α-actinin-3 in the mdx mouse means that dKO produce more absolute and specific force when compared to age matched mdx (see supplementary figures). Work done has been a parameter reported previously when comparing EC damage in dystrophic studies (25,52–57). Given that less work was done on aged mdx muscles compared with dKO during ECs means it is likely that the protective effect of the absence of α-actinin-3 is even larger than we report here.

There are less complex branched fibres in EDL muscles from dKO mice, which correlates with the protection from eccentric contraction force deficits.

In the dystrophinopathies, the number and complexity of pathologically branched fibres increases with age (18,25,36,38,42,45–48,51,58–61). A significant number of published reports have demonstrated a correlation between the extent and complexity of fibre branching in fast-twitch fibres and increased susceptibility to damage from eccentric contractions (25,36,38,48,62). Branching is an important and often overlooked pathological feature of the muscles in the dystrophinopathies and it has been shown that branching is responsible for the hypertrophy of fast-twitch skeletal muscles reported in the mdx mouse (42). We propose the increased susceptibility to injury during eccentric contractions in aged fast-twitch mdx muscles is due to morphological changes (branching) of fibres, which lead to weakened regions (branch points) that are the site of pathology and acute rupture during contraction (Fig. 6), rather than as a direct consequence of the absence of dystrophin (18,25,46,47). In support of this, Pavlaths group have demonstrated that reducing fibre branching in the mdx mouse induced by expression of the muscle specific olfactory receptor mOR23 protects against eccentric damage (48). In our initial study (10), we showed that it was only in 12 month dKO mice that the absence of α-actinin-3 was protective against eccentric damage, at younger ages the absence of α-actinin-3 conferred no protection despite the absence of dystrophin in both age groups. Here we show the protective effect of α-actinin-3 in mdx fast-twitch muscles at 12 months is even greater than we previously reported (10), furthermore, we show the Actn3KO protection is correlated with a reduction in both the number and complexity of branched fibres present in the mdx mouse at this age (Figs 35).

Eccentric force loss is gradual and reduced in dKO muscles

Further investigation into the isometric force loss at each of the three eccentric contractions used in the current study reveal that the force deficit in dKO muscles was graded (Fig. 2A). The aged dKO muscles lost ~36% of their starting force on the first contraction, dramatically different to the ~75% in aged mdx muscles (Fig. 2B left). This supports our earlier studies where we showed it was only the aged mdx EDL muscles, which lost the majority of their force on the first EC (18,25,36,38). We have proposed that this abrupt EC induced force loss in the aged mdx mouse is correlated with fibre rupture and tearing at branch points (25). The gradual force loss observed in dKO muscle resemble the drops in isometric force following EC seen in wild-type (WT) muscles with no branching (25,30,63–66) and young mdx muscles (25,30), which contain a simpler branching morphology, lacking the complex branches observed in aged mdx animals that cause the abrupt loss in isometric force.

Why does the absence of α-actinin-3 reduce fibre branching in the mdx EDL?

Our group has previously reported that Actn3 polymorphism switches the metabolism in type 2B fibres towards a slower oxidative metabolic state and reduces the 2B fibre diameters compared with WT muscles (17,19,22). There would be less shear stress on the fast-twitch fibres in dKO, thus protecting them from EC and potentially providing an explanation for the reduction in fibre branching we report here. Our argument here is that the Actn3 polymorphism switch of the 2B fibres to a slow-twitch metabolism is protective against EC force deficits, this notion is further supported by our recent publication showing that mdx slow-twitch soleus muscles are protected from eccentric force deficits throughout the life span of the mdx mouse due to reduced numbers and complexity of branched fibres relative to EDL muscles (30). Furthermore, there has been a long history in the muscular dystrophy field, which proposes shifting of the fast skeletal muscle fibres to a slow profile will confer protection to DMD boys (for a review see Hardee et al. (67)). Here we provide evidence that Actn3 polymorphism, which switches the anerobic metabolic profile of fast 2B fibres in mice to a slower oxidative pathway without altering the expression of the 2B myosin heavy chain, confers a protection from eccentric force deficits in 12 month mdx fast-twitch EDL, and this protection is correlated with a reduction in the number and complexity of branched fibres.

The molecular mechanism of Actn3KO protection is also likely due to an increase in SERCA1

It is well accepted that the absence of dystrophin in the dystrophinopathies, like DMD, triggers skeletal muscle fibre necrosis due to pathological [Ca2+]in regulation (40). Several studies have shown that the skeletal muscle pathology in the dystrophin-deficient mdx mouse can be ameliorated by overexpressing or pharmacologically activating the SR Ca2+ pump, SERCA1 (27,28,31). Previously, our group has shown that one consequence of the Actn3KO is a marked increase of SERCA1 protein in fast-twitch skeletal muscle (20,29). In this study we have shown that at 12 months of age dKO mice have a two-fold increase in the SR Ca2+ pump SERCA1 compared to age-matched dystrophin-deficient mdx mice (Fig. 7). This level of increase is similar to that described by Mázala et al. (28) when using SERCA1 overexpression, and is one likely explanation for the protection conferred by the Actn3 polymorphism in our dKO mouse. Furthermore, this work provides additional support for the physiological activation of SERCA1 in the skeletal muscle as a potential novel therapeutic target for the treatment of DMD.

If branches are weak, why do they persist in the dystrophic muscle?

We have hypothesized (25,38,46,68) that branches are relatively stable within the intact muscle until their number and complexity reach ‘tipping point’. Below this ‘tipping point’ a muscle can contain branched fibres with no loss of mechanical stability (see Kiriaev et al. (30)). Past ‘tipping point’ fibre branching makes the fibre susceptible to mechanical strains, which elicit rupture at one or more branch nodes in the branched fibre syncytium and results in catastrophic failure of the branched fibre unit. If these structural branch failures occur during a strong EC, like the ones we use here in vitro, there will be a positive feedback loop placing additional stress on the remaining complex branched fibres and as they rupture so will the remaining branched fibres, which have passed ‘tipping point’. However, if the mouse does not encounter eccentric strains of this magnitude these dystrophin-deficient animals can live largely asymptomatically past 108 weeks of age. It is only in the old mdx mouse that we start to see them die earlier than age matched controls (69,70), and we correlate this shortened life span with the degree and complexity of muscle fibre branching passing the ‘tipping point’ where a significant proportion of branches can no longer withstand the normal stresses and strains of muscle contraction.

Summary

The total absence of α-actinin-3 from the Z-discs of fast-twitch skeletal muscle fibres results in a switch to an oxidative metabolic pathway and increases in the sarcoplasmic reticulum Ca2+ pump protein SERCA1. These changes are correlated with a reduction in the occurrence of fast-twitch muscle fibre branching in aged dKO mice, which we propose confers the fast-twitch EDL muscles with some protection from EC induced force deficits. These results have implications for disease progression in the ~16% of boys with dystrophin-deficient DMD who also have the common null polymorphism (R577X).

Materials and Methods

Ethics approval

Research and animal care procedures were approved by the Western Sydney University Animal Ethics Committee (A12346) and Murdoch Children’s Research Institute (MCRI) animal ethics committees and performed in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes as laid out by the National Health and Medical Research Council of Australia.

Animals

Mdx (C57 BL/10SnSn-Dmdmdx/J) mice were obtained from Jackson Laboratories (Bar harbor, Me, USA). The Actn3 knockout line created in this laboratory (23) was backcrossed onto the C57BL/10 background for 10 generations before being crossed with the mdx line to produce mice lacking both α-actinin-3 and dystrophin, (dk)Actn3KO/mdx (dKO). Animals were housed at a maximum of four to a cage in an environment controlled room with a 12–12 h light–dark cycle and had access to food and water ad libitum according to animal holding facility arrangements.

Experiments were performed on 12 month old male mice with the dKO backgrounds (12.3 ± 0.09 months) and age matched mdx control mice (12.1 ± 0.1 months), genetic backgrounds were distinguished by genotyping. A total of 13 male mice were used in this study (n = 5 aged mdx and 8 dKO mice).

Muscle preparation

Animals were overdosed with isoflurane in an induction chamber, delivered at 4% in oxygen from a precision vaporizer. Animals were removed when they were not breathing and a cervical dislocation was immediately carried out. The fast-twitch EDL muscle was dissected from the hind limb in solution and tied by its tendons from one end to a dual force transducer/linear tissue puller (300 Muscle Lever; Aurora Scientific Instruments, ON, Canada) and secured to a base at the other end using 6–0 silk sutures (Pearsalls Ltd, Somerset, UK). The muscle was kept at room temperature during preparation in an organ bath containing Krebs solution with composition (in mM): 4.75 KCl, 118 NaCl, 1.18 KH2PO4, 1.18 MgSO4, 24.8 NaHCO3, 2.5 CaCl2 and 10 glucose, 0.1% foetal calf serum and bubbled continuously with carbogen (95% O2, 5% CO2) to maintain pH at 7.4. Krebs solution was used for dissecting, storage and contractile procedures.

The muscle was stimulated by delivering a current between two parallel platinum electrodes, using an electrical stimulator (701C stimulator; Aurora Scientific Instruments). All contractile procedures were designed, measured, and analyzed using the 615A Dynamic Muscle Control and Analysis software (DMC version 5.417 and DMA version 5.201; Aurora Scientific Instruments). At the start of the experiment, the muscle was set to optimal length (Lo), which will produce maximal twitch force, and measured using vernier muscle callipers. These contractile experiments were conducted on the EDL muscle and at a room temperature of ~20–22°C.

Initial maximum force

An initial supramaximal stimulus was given at 1 ms, 125 Hz for 1 s, and force produced for muscles recorded as Po, the maximum force output of the muscle at optimal/resting length Lo. Muscles then underwent an initial force frequency protocol, left to rest for 5 min (during which muscle length was reset to Lo with no stimulation in the organ bath), followed by the EC sequence and another 5 min rest before a final force frequency protocol.

Force frequency curve

Force-frequency curves were generated before and after the EC sequence to measure muscle contractile function throughout the study. Trains of stimuli were given 30s apart by different frequencies, including 2, 15, 25, 37.5, 50, 75, 100, 125, 150 Hz at 1 ms duration (width) width for 1 s and the force produced was measured.

A sigmoid curve relating the muscle force (P) to the stimulation frequency (f) was fitted by linear regression to this data.

The curve had the equation:

graphic file with name DmEquation1.gif (1)

From the fitted parameters of the curve, the following contractile properties were obtained: force developed at minimal (Pmin) and maximal (Pmax) stimulation at the conclusion of the force-frequency curve. Half-frequency (Kf) is the frequency at which the force developed is halfway between (Pmin) and (Pmax), and Hill coefficient (h), which provides a way to quantify the calcium binding affinity of the muscle during contraction. These were used for population statistics.

Eccentric contractions

A series of eccentric (lengthening) contractions where the contracted muscle was stretched 10% from Lo. At t = 0 s, the muscle was stimulated via supramaximal pulses of 1 ms duration (width) and 125 Hz frequency. At t = 0.9 s, after maximal isometric force was attained, each muscle was stretched 10% longer than their optimal length. The muscle was then held at this length for 2 s before returning to optimal length. Electrical stimulus was stopped at t = 5 s. This EC procedure was performed 3 times at intervals of 3 min. The force measured at each EC was expressed as a percentage of the force produced during the first (initial) contraction.

Twitch kinetics

Twitch force and kinetics were measured at two time points throughout the contractile protocol to compared differences between pre EC and post-EC kinetics. The twitches were performed at 2 Hz, for 1 ms (width) and 1 s duration immediately after initial maximum force (before) and 5 min following the EC protocol (after). The following parameters were collected: peak twitch force expressed as a ratio of peak tetanic force, half relaxation time and time to peak.

Work done

Work is an energy quantity given by force times distance, this measurement was used to provide a quantitative estimate of the EC-inducing forces. The work done to stretch the muscle was calculated from the force tracings through multiplying the area underneath the lengthening phase of the force tracing with the velocity of lengthening.

Brooks et al. (71) examined the effect of various parameters on the force deficit produced by eccentric contractions, and found that the work done to stretch the muscle during the lengthening phase of an EC was the best predictor of the magnitude of the force deficit (52,57,72). Hence, this measure serves as a useful estimate of the mechanical stresses imposed on a muscle during an EC.

Muscle mass

After contractile procedures were completed, the EDL muscle was removed from the organ bath and tendons trimmed. The muscles were blotted lightly (Whatmans filter paper DE81 grade) and weighed using an analytical balance (GR Series analytical electronic balance).

Western blot and automated western blot protocol

Snap frozen extensor digitorum longus (EDL) muscles (n = 3 muscles/genotype) were lysed by sonication in 4% SDS lysis buffer containing 65 mM Tris pH 6.8, 4% SDS, 1:500 Protease Inhibitor Cocktail solution (Sigma-Aldrich), 1X PhosSTOP Phosphatase Inhibitor Cocktail solution (Sigma-Aldrich) and Milli-Q water. Total protein concentrations were then assessed using Direct Detect (ThermoFisher Scientific) as per manufacturer’s instructions. Protein simple automated western blot was then performed using 0.2 mg/mL of protein lysates, and primary antibodies including α-Sarcomeric actin (A2172, 5C5, Sigma-Aldrich, 1:10 000) and SERCA1 (ab109899, Abcam, 1:5000), and their respective secondary antibodies in the 12–230 KDa capillary cartridge separation module (Protein Simple) as per manufacturer’s instructions. Protein analyses were performed using Compass software (Protein Simple). All results were then normalized to α-actin abundance and presented relative to healthy age matched WT controls (C57BL/10).

Skeletal muscle single fibre enzymatic isolation and morphology

Following contractile procedures and weighing, EDL muscles were digested in Krebs solution (without FCS) containing 3 mg/ml collagenase type IV A (Sigma Aldrich, MO, USA), gently bubbled with carbogen (95% O2, 5% CO2) and maintained at 37°C. After 25 min, the muscle was removed from solution, rinsed in Krebs solution containing 0.1% foetal calf serum and placed in a relaxing solution with the following composition (mM): 117 K+, 36 Na+, 1 Mg2+, 60 Hepes, 8 ATP, 50 EGTA (note: internal solution due to chemically skinning by high EGTA concentration). Each muscle was then gently agitated using pipette suction, releasing individual fibres from the muscle mass and ensuring fibre distribution throughout the solution. Using a pipette 0.5 mL of solution was drawn and placed on a glass slide for examination.

Where a long fibre covered several fields of the microscope view a series of overlapping photomicrographs were taken and these were then stitched together using the Corel draw graphic package. A total of 667 fibres from 9 EDL muscles were counted; 207 fibres from 4 aged mdx and 460 from 5 dKO animals. Only intact fibres with no evidence of digestion damage were selected for counting.

Statistical analyses

Data was presented as means ± SD, Differences occurring between genotypes were assessed by individual student’s unpaired t-tests (unless specified) conducted at a significance level of 5%. All statistical tests and curve fitting were performed using a statistical software package Prism Version 7 (GraphPad, CA, USA).

Supplementary Material

Supplementary_figures_ddab326

Acknowledgements

This project was funded in part by grants from the National Health and Medical Research Council of Australia (ID:P00024683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflicts of Interest statement. Authors have read the journal’s policy on disclosure of potential conflict of interest. The authors declare that they have no competing interests.

Contributor Information

Leonit Kiriaev, School of Medicine, Western Sydney University, Sydney, NSW 2560, Australia.

Peter J Houweling, Murdoch Children’s Research Institute, Melbourne, Victoria 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Victoria 3052, Australia.

Kathryn N North, Murdoch Children’s Research Institute, Melbourne, Victoria 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Victoria 3052, Australia.

Stewart I Head, School of Medicine, Western Sydney University, Sydney, NSW 2560, Australia; Murdoch Children’s Research Institute, Melbourne, Victoria 3052, Australia.

References

  • 1. Rodino-Klapac, L.R., Mendell, J.R. and Sahenk, Z. (2013) Update on the treatment of Duchenne muscular dystrophy. Curr. Neurol. Neurosci. Rep., 13, 332. 10.1007/s11910-012-0332-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Hoffman, E.P. and McNally, E.M. (2014) Exon-skipping therapy: a roadblock, detour, or bump in the road? Sci. Transl. Med., 6, 230fs214. 10.1126/scitranslmed.3008873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Shieh, P.B. (2015) Duchenne muscular dystrophy: clinical trials and emerging tribulations. Curr. Opin. Neurol., 28, 542–546. [DOI] [PubMed] [Google Scholar]
  • 4. Bengtsson, N.E., Seto, J.T., Hall, J.K., Chamberlain, J.S. and Odom, G.L. (2016) Progress and prospects of gene therapy clinical trials for the muscular dystrophies. Hum. Mol. Genet., 25, R9–R17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Aartsma-Rus, A. and Muntoni, F. (2013) 194th ENMC international workshop. 3rd ENMC workshop on exon skipping: towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8–10 December 2012, Naarden, the Netherlands. Neuromuscul. Disord., 23, 934–944. [DOI] [PubMed] [Google Scholar]
  • 6. Fairclough, R.J., Wood, M.J. and Davies, K.E. (2013) Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat. Rev. Genet., 14, 373–378. [DOI] [PubMed] [Google Scholar]
  • 7. Hoffman, E.P. and Connor, E.M. (2013) Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies. Discov. Med., 16, 233–239. [PubMed] [Google Scholar]
  • 8. Lu, Q.L., Cirak, S. and Partridge, T. (2014) What can we learn from clinical trials of exon skipping for DMD? Mol. Ther., 3, e152. 10.1038/mtna.2014.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Ceco, E. and McNally, E.M. (2013) Modifying muscular dystrophy through transforming growth factor-β. FEBS J., 280, 4198–4209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Hogarth, M.W., Houweling, P.J., Thomas, K.C., Gordish-Dressman, H., Bello, L., Pegoraro, E., Hoffman, E.P., Head, S.I. and North, K.N. (2017) Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy. Nat. Commun., 8, 14143. 10.1038/ncomms14143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. North, K.N., Yang, N., Wattanasirichaigoon, D., Mills, M., Easteal, S. and Beggs, A.H. (1999) A common nonsense mutation results in α-actinin-3 deficiency in the general population. Nat. Genet., 21, 353–354. [DOI] [PubMed] [Google Scholar]
  • 12. Berman, Y. and North, K.N. (2010) A gene for speed: the emerging role of alpha-actinin-3 in muscle metabolism. Physiology (Bethesda), 25, 250–259. [DOI] [PubMed] [Google Scholar]
  • 13. Lee, F.X.Z., Houweling, P.J., North, K.N. and Quinlan, K.G.R. (2016) How does α-actinin-3 deficiency alter muscle function? Mechanistic insights into ACTN3, the ‘gene for speed’. Biochim. Biophys. Acta, 1863, 686–693. [DOI] [PubMed] [Google Scholar]
  • 14. Patel, T.J. and Lieber, R.L. (1997) Force transmission in skeletal muscle: from actomyosin to external tendons. Exerc. Sport Sci. Rev., 25, 321–363. [PubMed] [Google Scholar]
  • 15. Yang, N., Mac Arthur, D.G., Gulbin, J.P., Hahn, A.G., Beggs, A.H., Easteal, S. and North, K. (2003) ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet., 73, 627–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Houweling, P.J., Papadimitriou, I.D., Seto, J.T., Pérez, L.M., Coso, J.D., North, K.N., Lucia, A. and Eynon, N. (2018) Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and disease. Hum. Mutat., 39, 1774–1787. [DOI] [PubMed] [Google Scholar]
  • 17. Chan, S., Seto, J.T., Mac Arthur, D.G., Yang, N., North, K.N. and Head, S.I. (2008) A gene for speed: contractile properties of isolated whole EDL muscle from an alpha-actinin-3 knockout mouse. Am. J. Physiol. Cell Physiol., 295, C897–C904. [DOI] [PubMed] [Google Scholar]
  • 18. Chan, S., Seto, J.T., Houweling, P.J., Yang, N., North, K.N. and Head, S.I. (2011) Properties of extensor digitorum longus muscle and skinned fibers from adult and aged male and femaleActn3knockout mice. Muscle Nerve, 43, 37–48. [DOI] [PubMed] [Google Scholar]
  • 19. Seto, J.T., Lek, M., Quinlan, K.G.R., Houweling, P.J., Zheng, X.F., Garton, F., Macarthur, D.G., Raftery, J.M., Garvey, S.M., Hauser, M.A.et al. (2011) Deficiency of α-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling. Hum. Mol. Genet., 20, 2914–2927. [DOI] [PubMed] [Google Scholar]
  • 20. Head, S.I., Chan, S., Houweling, P.J., Quinlan, K.G.R., Murphy, R., Wagner, S., Friedrich, O. and North, K.N. (2015) Altered Ca2+ kinetics associated with α-Actinin-3 deficiency may explain positive selection for ACTN3 null allele in human evolution. PLoS Genet., 11, e1004862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Wyckelsma, V.L., Venckunas, T., Houweling, P.J., Schlittler, M., Lauschke, V.M., Tiong, C.F., Wood, H.D., Ivarsson, N., Paulauskas, H., Eimantas, N.et al. (2021) Loss of α-actinin-3 during human evolution provides superior cold resilience and muscle heat generation. Am. J. Hum. Genet., 108, 446–457. 10.1371/journal.pgen.1004862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Macarthur, D.G., Seto, J.T., Chan, S., Quinlan, K.G.R., Raftery, J.M., Turner, N., Nicholson, M.D., Kee, A.J., Hardeman, E.C., Gunning, P.W.et al. (2008) An Actn3 knockout mouse provides mechanistic insights into the association between -actinin-3 deficiency and human athletic performance. Hum. Mol. Genet., 17, 1076–1086. [DOI] [PubMed] [Google Scholar]
  • 23. Macarthur, D.G., Seto, J.T., Raftery, J.M., Quinlan, K.G., Huttley, G.A., Hook, J.W., Lemckert, F.A., Kee, A.J., Edwards, M.R., Berman, Y.et al. (2007) Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat. Genet., 39, 1261–1265. [DOI] [PubMed] [Google Scholar]
  • 24. Quinlan, K.G.R., Seto, J.T., Turner, N., Vandebrouck, A., Floetenmeyer, M., Macarthur, D.G., Raftery, J.M., Lek, M., Yang, N., Parton, R.G.et al. (2010) α-Actinin-3 deficiency results in reduced glycogen phosphorylase activity and altered calcium handling in skeletal muscle. Hum. Mol. Genet., 19, 1335–1346. [DOI] [PubMed] [Google Scholar]
  • 25. Kiriaev, L., Kueh, S., Morley, J.W., North, K.N., Houweling, P.J. and Head, S.I. (2018) Branched fibers from old fast-twitch dystrophic muscles are the sites of terminal damage in muscular dystrophy. Am. J. Physiol. Cell Physiol., 314, C662–C674. [DOI] [PubMed] [Google Scholar]
  • 26. Kiriaev L, Kueh S, Morley JW, North KN, Houweling PJ & Head SI. (2021a). Lifespan analysis of dystrophic mdx fast-twitch muscle morphology and its impact on contractile function. Western Sydney University. https://www.frontiersin.org/articles/10.3389/fphys.2021.771499/abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Goonasekera, S.A., Lam, C.K., Millay, D.P., Sargent, M.A., Hajjar, R.J., Kranias, E.G. and Molkentin, J.D. (2011) Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J. Clin. Invest., 121, 1044–1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Mázala, D.A.G., Pratt, S.J.P., Chen, D., Molkentin, J.D., Lovering, R.M. and Chin, E.R. (2015) SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. American journal of physiology-cell. Phys. Ther., 308, C699–C709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Garton, F.C., Houweling, P.J., Vukcevic, D., Meehan, L.R., Lee, F.X.Z., Lek, M., Roeszler, K.N., Hogarth, M.W., Tiong, C.F., Zannino, D.et al. (2018) The effect of ACTN3 gene doping on skeletal muscle performance. Am. J. Hum. Genet., 102, 845–857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Kiriaev, L., Kueh, S., Morley, J.W., Houweling, P.J., Chan, S., North, K.N. and Head, S.I. (2021b) Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the mdx mouse. Am. J. Physiol. Cell Physiol., 0, null. 10.1152/ajpcell.00122.2021. [DOI] [PubMed] [Google Scholar]
  • 31. Nogami, K.I., Maruyama, Y., Sakai-Takemura, F., Motohashi, N., Elhussieny, A., Imamura, M., Miyashita, S., Ogawa, M., Noguchi, S., Tamura, Y.et al. (2021) Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice. Hum. Mol. Genet., 30, 1006–1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Peczkowski, K.K., Rastogi, N., Lowe, J., Floyd, K.T., Schultz, E.J., Karaze, T., Davis, J.P., Rafael-Fortney, J.A. and Janssen, P.M.L. (2020) Muscle twitch kinetics are dependent on muscle group, disease state, and age in Duchenne muscular dystrophy mouse models. Front. Physiol., 11, 568909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Celichowski, J. and Grottel, K. (1993) Twitch/tetanus ratio and its relation to other properties of motor units. Neuroreport, 5, 201–204. [DOI] [PubMed] [Google Scholar]
  • 34. Hettige, P., Tahir, U., Nishikawa, K.C. and Gage, M.J. (2020) Comparative analysis of the transcriptomes of EDL, psoas, and soleus muscles from mice. BMC Genomics, 21, 808. 10.1097/00001756-199312000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. McCully, K.K. and Faulkner, J.A. (1985) (1985). Injury to skeletal muscle fibers of mice following lengthening contractions. J. Appl. Physiol., 59, 119–126. [DOI] [PubMed] [Google Scholar]
  • 36. Head, S.I., Williams, D.A. and Stephenson, D.G. (1992) Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice. Proc. Biol. Sci., 248, 163–169. [DOI] [PubMed] [Google Scholar]
  • 37. Head, S., Williams, D. and Stephenson, G. (1994) Increased susceptibility of EDL muscles from mdx mice to damage induced by contraction with stretch. J. Muscle Res. Cell Motil., 15, 490–492. [PubMed] [Google Scholar]
  • 38. Chan, S., Head, S.I. and Morley, J.W. (2007) Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. Am. J. Physiol. Cell Physiol., 293, C985–C992. [DOI] [PubMed] [Google Scholar]
  • 39. Schiaffino, S. and Reggiani, C. (2011) Fiber types in mammalian skeletal muscles. Physiol. Rev., 91, 1447–1531. [DOI] [PubMed] [Google Scholar]
  • 40. Allen, D.G., Whitehead, N.P. and Froehner, S.C. (2016) Absence of dystrophin disrupts skeletal muscle Signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol. Rev., 96, 253–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Williams, D.A., Head, S.I., Lynch, G.S. and Stephenson, D.G. (1993) Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice. J. Physiol., 460, 51–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Faber, R.M., Hall, J.K., Chamberlain, J.S. and Banks, G.B. (2014) Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice. Skelet. Muscle, 4, 10. 10.1186/2044-5040-4-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Pratt, S.J.P., Valencia, A.P., Le, G.K., Shah, S.B. and Lovering, R.M. (2015) Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice. Front. Physiol., 6, 252–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Massopust, R.T., Lee, Y.I., Pritchard, A.L., Nguyen, V.M., McCreedy, D.A. and Thompson, W.J. (2020) Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss. Sci. Rep., 10, 17248. 10.1038/s41598-020-74192-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Head, S.I., Stephenson, D.G. and Williams, D.A. (1990) Properties of enzymatically isolated skeletal fibres from mice with muscular dystrophy. J. Physiol., 422, 351–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Head, S.I. (2010) Branched fibres in old dystrophic mdx muscle are associated with mechanical weakening of the sarcolemma, abnormal Ca2+ transients and a breakdown of Ca2+ homeostasis during fatigue. Exp. Physiol., 95, 641–656. [DOI] [PubMed] [Google Scholar]
  • 47. Head S. (2012). A two stage model of skeletal muscle necrosis in muscular dystrophy – the role of fiber branching in the terminal stage. In Hegde, M. (ed.), Muscular Dystrophy. Intech, Rijeka, Croatia, pp. 475–498. [Google Scholar]
  • 48. Pichavant, C., Burkholder, T.J. and Pavlath, G.K. (2015) Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress. Skelet. Muscle, 6, 2. 10.1186/s13395-016-0077-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Bell, C.D. and Conen, P.E. (1968) Histopathological changes in Duchenne muscular dystrophy. J. Neurol. Sci., 7, 529–544. [DOI] [PubMed] [Google Scholar]
  • 50. Schmalbruch, H. (1984) Regenerated muscle fibers in Duchenne muscular dystrophy: a serial section study. Neurology, 34, 60–65. [DOI] [PubMed] [Google Scholar]
  • 51. Duddy, W., Duguez, S., Johnston, H., Cohen, T.V., Phadke, A., Gordish-Dressman, H., Nagaraju, K., Gnocchi, V., Low, S. and Partridge, T. (2015) Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia. Skelet. Muscle, 5, 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Stevens, E.D. and Faulkner, J.A. (2000) The capacity of mdx mouse diaphragm muscle to do oscillatory work. J. Physiol., 522, 457–466. 10.1111/j.1469-7793.2000.t01-3-00457.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Lynch, G.S., Hinkle, R.T., Chamberlain, J.S., Brooks, S.V. and Faulkner, J.A. (2001a) Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J. Physiol., 535, 591–600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Lynch, G.S., Hinkle, R.T. and Faulkner, J.A. (2001b) Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment. Neuromuscul. Disord., 11, 192–196. [DOI] [PubMed] [Google Scholar]
  • 55. Gregorevic, P., Plant, D.R., Leeding, K.S., Bach, L.A. and Lynch, G.S. (2002) Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am. J. Pathol., 161, 2263–2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Faulkner, J.A., Ng, R., Davis, C.S., Li, S. and Chamberlain, J.S. (2008) Diaphragm muscle strip preparation for evaluation of gene therapies in mdx mice. Clin. Exp. Pharmacol. Physiol., 35, 725–729. [DOI] [PubMed] [Google Scholar]
  • 57. Lindsay, A., Baumann, C.W., Rebbeck, R.T., Yuen, S.L., Southern, W.M., Hodges, J.S., Cornea, R.L., Thomas, D.D., Ervasti, J.M. and Lowe, D.A. (2020) Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators. Skelet. Muscle, 10, 3. 10.1186/s13395-020-0221-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Lovering, R.M., Michaelson, L. and Ward, C.W. (2009) Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling. Am. J. Phys. Cell Phys., 297, C571–C580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Buttgereit, A., Weber, C., Garbe, C.S. and Friedrich, O. (2013) From chaos to split-ups - SHG microscopy reveals a specific remodelling mechanism in ageing dystrophic muscle. J. Pathol., 229, 477–485. [DOI] [PubMed] [Google Scholar]
  • 60. Pichavant, C. and Pavlath, G.K. (2014) Incidence and severity of myofiber branching with regeneration and aging. Skelet. Muscle, 4, 9. 10.1186/2044-5040-4-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Ben Larbi, S., Saclier, M., Fessard, A., Juban, G. and Chazaud, B. (2021) Histological analysis of tibialis anterior muscle of DMDmdx4Cv mice from 1 to 24 months. J Neuromuscul Dis, 8, 513–524. [DOI] [PubMed] [Google Scholar]
  • 62. Dellorusso, C., Crawford, R.W., Chamberlain, J.S. and Brooks, S.V. (2001) Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J. Muscle Res. Cell Motil., 22, 467–475. [DOI] [PubMed] [Google Scholar]
  • 63. Morgan, D.L. (1990) New insights into the behavior of muscle during active lengthening. Biophys. J., 57, 209–221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Lieber, R.L., Woodburn, T.M. and Friden, J. (1991) Muscle damage induced by eccentric contractions of 25% strain. J. Appl. Physiol., 70, 2498–2507. [DOI] [PubMed] [Google Scholar]
  • 65. Brooks, S.V. (1998) Rapid recovery following contraction-induced injury to in situ skeletal muscles in mdx mice. J. Muscle Res. Cell Motil., 19, 179–187. [DOI] [PubMed] [Google Scholar]
  • 66. Froehner, S.C., Reed, S.M., Anderson, K.N., Huang, P.L. and Percival, J.M. (2014) Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice. Hum. Mol. Genet., 24, 492–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Hardee, J.P., Martins, K.J.B., Miotto, P.M., Ryall, J.G., Gehrig, S.M., Reljic, B., Naim, T., Chung, J.D., Trieu, J., Swiderski, K.et al. (2021) Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity. Molecular. Metabolism, 45, 101157. 10.1016/j.molmet.2020.101157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Chan, S. and Head, S.I. (2011) The role of branched fibres in the pathogenesis of Duchenne muscular dystrophy. Exp. Physiol., 96, 564–571. [DOI] [PubMed] [Google Scholar]
  • 69. Chamberlain, J.S., Metzger, J., Reyes, M., Townsend, D. and Faulkner, J.A. (2007) Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J., 21, 2195–2204. [DOI] [PubMed] [Google Scholar]
  • 70. Li, D., Long, C., Yue, Y. and Duan, D. (2009) Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum. Mol. Genet., 18, 1209–1220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Brooks, S.V., Zerba, E. and Faulkner, J.A. (1995) Injury to muscle fibres after single stretches of passive and maximally stimulated muscles in mice. J. Physiol., 488, 459–469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Hunter, K.D. and Faulkner, J.A. (1997) Pliometric contraction-induced injury of mouse skeletal muscle: effect of initial length. J. Appl. Physiol., 82, 278–283. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary_figures_ddab326

Articles from Human Molecular Genetics are provided here courtesy of Oxford University Press

RESOURCES